The Endocrine Society is pleased a South Dakota bill that would have barred healthcare providers from treating transgender teenagers using evidence-based clinical practice guidelines is not moving forward this session. Several states are considering legislation that would carry penalties of jail time and fines for healthcare providers who treat transgender teenagers using evidence-based practices. These...
Author: Derek Bagley
U.S. Representative Charlie Crist (D-St. Petersburg) today announced the introduction of the Affordable Insulin for All Act (H.R. 5749) — legislation that would slash the price of life-sustaining insulin for every American living with diabetes. The bill would create the American Insulin Program, expanding the deep discount drug manufacturers currently give to Medicaid patients, to every American who...
An ACTH assay’s accuracy became so concerning that it warranted a paper in the Journal of the Endocrine Society that detailed five separate cases. Raising awareness of this rare but serious issue can avoid misdiagnoses that put patients in peril. This past April, an article appeared in the Journal of the Endocrine Society titled, “Assay-Specific...
Endocrine News gets the patient and physician perspective on thyroid eye disease. Patients discuss how it has affected their lives and clinicians explain the limited treatment choices. However, new options may be available soon. Christine Gustafson, of Monterey, Calif., swam a mile a day and biked everywhere she went. When she noticed her heart was...
BPA Exposure Leads to Abnormal Estrous Cycle and Folliculogenesis, Mouse Study Finds
Exposure to bisphenol A (BPA), even at environmentally low doses, disrupts the preovulatory luteinizing hormone (LH) surge and leads to abnormal estrous cycle and folliculogenesis, according to a study recently published in Endocrinology. This disruption is reversible following adult exposure, but it persists into adulthood after neonatal exposure. Researchers led by David Lopez-Rodriguez, MSc, at the neuroendocrinology...
Review Examines Optimal Care for Patients with 46,XY Differences of Sex Development
Treating patients with 46,XY differences of sex development (DSD) will require interdisciplinary healthcare teams trained to care for patients and their families, according to a paper recently published in Endocrine Reviews. The review, by Amy B. Wisniewski, of Oklahoma State University in Stillwater, et al., points out that DSD are a heterogenous group of congenital...